DutyPills.com

Long-acting insulin analogue

Insulin Glargine with liver impairment: dosing and safety

The liver is the main site of metabolism for many medications including Insulin Glargine (Insulin Glargine). Liver impairment slows clearance and can raise plasma levels of Insulin Glargine above the intended range, amplifying side effects. People with chronic liver disease, recent hepatitis or significantly raised liver enzymes need a tailored approach to Insulin Glargine at 100 IU/mL.

Why liver function matters

Insulin Glargine undergoes hepatic metabolism through CYP enzymes for many medications. Reduced hepatic function slows this metabolism, prolongs the half-life and raises plasma concentrations. Insulin glargine binds the insulin receptor with similar affinity to human insulin, activating intracellular signalling that increases glucose uptake in muscle and adipose tissue, suppresses hepatic g… The prescribing information typically classifies severity by Child-Pugh score (A mild, B moderate, C severe) and gives dose adjustments accordingly.

Practical guidance

According to the prescribing information for Insulin Glargine, baseline liver function tests are recommended before starting Insulin Glargine in any patient with risk factors and periodically during treatment in chronic liver disease. Severe impairment (Child-Pugh C) often contraindicates Insulin Glargine or requires substantial dose reduction; mild impairment usually permits standard 100 IU/mL with closer monitoring.

Frequently asked questions

Is Insulin Glargine safe with liver problems?

Mild liver impairment typically allows Insulin Glargine at standard or slightly reduced 100 IU/mL with monitoring. Moderate-to-severe impairment often requires substantial dose reduction. Severe (Child-Pugh C) impairment may contraindicate Insulin Glargine entirely.

Will Insulin Glargine damage my liver?

Most Long-acting insulin analogue medications at standard 100 IU/mL doses do not harm a healthy liver. A small subset can produce drug-induced liver injury in susceptible patients, usually detected by routine ALT/AST monitoring. The prescribing information for Insulin Glargine lists the documented risk.

Products containing Insulin Glargine

More on Insulin Glargine

The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.